Distribution of total serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: The Third National Health and Nutrition Examination Survey

Annals of Epidemiology

Volumn 14, Issue 3, 2004, Pages 229-233

  Gillum, R F ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

Adolescence; Blood Pressure; HDL Cholesterol; Lipoproteins; Obesity; Risk Factors; Serum; Total Homocysteine

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE;

ADOLESCENT; BLOOD LEVEL; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; MASS SCREENING; METABOLIC SYNDROME X; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHOOL CHILD; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 1342302878     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00242-4     Document Type: Article

References (38)

1. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
2. Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease. Lancet. 354:1999;407-413.
3. Eikelboom J.W., Lonn E., Genest J. Jr., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 131:1999;363-375.
4. Gallisti S., Sudi K.M., Erwa W., Aigner R., Borkenstein M. Determinants of homocysteine during weight reduction in obese children and adolescents. Metabolism. 50:(10):2001;1220-1223.
5. Rauh M., Verwied S., Knerr I., Dorr H.G., Sonnichsen A., Koletzko B. Homocysteine concentrations in a German cohort of 500 individuals: reference ranges and determinants of plasma levels in healthy children and their parents. Amino Acids. 20:(4):2001;409-418.
6. Jacques P.F., Rosenberg I.H., Rogers G., Selhub J., Bowman B.A., Gunter E.W., et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 69:1999;482-489.
7. Morris M.S., Jacques P.F., Selhub J., Rosenberg I.H. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 152:2000;140-148.
8. Greenlund K.J., Srinivasan S.R., Xu J., Dalteres E. Jr., Myers L., Pickoff A., et al. Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children. The Bogalusa Heart Study. Circulation. 99:1999;2144-2149.
9. Tonstad S., Refsum H., Sivertsen M., Christophersen B., Ose L., Ueland P.M. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res. 40:1996;47-52.
10. Tonstad S., Joakimsen O., Stensland-Bugge E., Leren T.P., Ose L., Russell D., Bonaa K.H. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 16:1996;984-991.
11. Tonstad S., Refsum H., Ueland P.M. Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation. 96:1997;1803-1808.
12. Gallisti S., Sudi K., Mangge H., Erwa W., Borkenstein M. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care. 23:2000;1348-1352.
13. Osganian S.K., Stampfer M.J., Spiegelman D., Rimm E., Cutler J.A., Feldman H.A., et al. Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA. 281:1999;1189-1196.
14. Wiltshire E., Thoma D.W., Baghurst P., Couper J. Reduced total homocyst(e)ine in children and adolescents with type 1 diabetes. J Pediatr. 200:2000;888-893.
15. Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381.
16. Liese A.D., Mayer-Davis E.J., Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 20:1998;157-172.
17. Fagan T.C., Deedwania P.C. The cardiovascular dysmetabolic syndrome. Am J Med. 105:1998;77S-82S.
18. Giles W.H., Croft J.B., Greenlund K.J., Ford E.S., Kittner J.S. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey. Am Heart J. 139:2000;446-453.
19. Morris M.S., Jacques P.F., Selhub J., Rosenberg I.H. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 152:2000;140-148.
20. National Center for Health Statistics Plan and operation of the Third National Health and Nutrition Examination Survey. 1988-94. National Center for Health Statistics. Vital Health Stat. 1:(32):1994;27.
21. Vargas C.M., Burt Vicki L., Gillum R.F. Cardiovascular disease in the NHANES III. Ann Epidemiol. 7:1997;523-525.
22. Gunter E.W., Lewis B.G., Koncikowski S.M. Laboratory procedures use for the Third National Health and Nutrition Examination Survey, 1988-94 [CD ROM]. National Center for Health Statistics. 1996.
23. Wright J.W., Bialostosky K., Gunter E.W., Carroll M.D., Najjar M.F., Bowman B.A., et al. Blood folate and vitamin B12: United States, 1988-94. National Center for Health Statistics. Vital Health Stat. 11:(243):1998;1-44.
24. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr. 422:1987;43-52.
25. McKinley M.C., Strain J.J., McPartlin J., Scott J.M., McNulty H. Plasma homocysteine is not subject to seasonal variation. Clin Chem. 47:(8):2001;1430-1436.
26. Harris M.I., Eastman R.C., Cowie C.C., Flegal K.M., Eberhardt M.S. Racial and ethnic differences in glycemic control of adults with Type 2 diabetes. Diabetes Care. 22:1999;403-408.
27. Westat Inc. National Health and Nutrition Examination Survey III. Body Measurements (Anthropometry). 1996;National Center for Health Statistics, Hyattsville, Maryland.
28. Flegal K.M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 22:1998;39-47.
29. SAS Institute Inc. SAS Procedures Guide: statistics, version 6 edition. 1990;SAS Institute Inc, Cary NC. 212:1351-1456.
30. Landis J.R., Lepkowski J.M., Eklund S.A., Stehouwer S.A. A statistical methodology for analyzing data from a complex survey, the First National Health and Nutrition Examination Survey. National Center for Health Statistics. Vital and Health Statistics. Series 2, No. 92. DHHS Pub. No. (PHS) 82-1366. Public Health Service. 1982;US Government Printing Office, Washington, D.C.
31. Shah B.V., Barnwell B.G., Bieler G.S. SUDAAN Software for the Statistical Analysis of Correlated Data User's Manual Release 7.0. 1996;Research Triangle Institute, Research Triangle Park, North Carolina.
32. Finkelstein J.D. The regulation of homocysteine metabolism. Graham I., Refsum H., Rosenberg I.H., Ueland P.M., Shuman J.M. Homocysteine Metabolism: From Basic Science to Clinical Medicine. 1997;3-10 Kluwer Academic Publishers, Boston.
33. Hultberg B., Agardh E., Andersson A., Brattstrom L., Isaksson A., Isreaelsson B., et al. Increased levels of plasma homocysteine associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest. 51:1991;277-282.
34. Fonseca V.A., Mudaliar S., Schmidt B., Fink L.M., Kern P.A., Henry R.R. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic by not type 2 diabetic subjects. Metabolism. 47:1998;686-689.
35. Anderson R.A. Contributing factors to insulin resistance. Role of dietary factors: micronutrients. Nutr Rev. 58:(II):2000;S10-S11.
36. Smulders Y.M., Rakic M., Slaats E.H., Treskes M., Sijbrands E.J., Odekerken D.A., et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care. 21:1999;125-132.
37. Rodriguez-Moran M., Guerrero-Romero F. The parental phenotype of diabetes, but not of essential hypertension, is linked to the development of metabolic syndrome in Mexican individuals. Acta Diabetol. 38:(2):2001;87-91.
38. Thomas J., Semenya K., Neser W.B., Thomas D.S., Gillum R.F. Parental hypertension as a predictor of hypertension in black physicians: The Meharry Cohort Study. J Natl Med Assoc. 82:1990;409-412.